NCT06213311 2026-01-14A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell LymphomaM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled
NCT06670105 2025-09-17A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell LymphomaM.D. Anderson Cancer CenterPhase 2 Withdrawn
NCT06497452 2024-07-11GLOFTSTThe First Affiliated Hospital of Soochow UniversityRecruiting50 enrolled